No PSA Recurrence at 24 Months With Apalutamide Plus ADT After Radical Prostatectomy
(MedPage Today) -- SAN ANTONIO--More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen deprivation therapy (ADT)...